Cara Therapeutics (CARA) Tops Q3 EPS by 5c

November 3, 2016 4:23 PM EDT
Get Alerts CARA Hot Sheet
Trade CARA Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Cara Therapeutics (NASDAQ: CARA) reported Q3 EPS of ($0.42), $0.05 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Cara Therapeutics (CARA) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment